The effect of pharmacist medicine counselling on treatment goals in renal dialysis patients

Not Applicable

• Conditions: End Stage Renal Disease; Renal and Urogenital - Kidney disease; Public Health - Health service research

• Registration Number: ACTRN12613000564752
• Lead Sponsor: Waikato District Health Board

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-05-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Patients with end stage renal disease who recieve dialysis as outpatients

Exclusion Criteria

-Inability to consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum phospate levels in millimoles per litre (mmol/L). This is measured via serum assay (phosphate level) monthly.[Six months and twelve months]